[ROENTGEN DIAGNOSIS OF RENAL HYPERTENSION CAUSED BY OBSTRUCTION. (NEW METHODS AND RESULTS)].

W. Porstmann,L. Wierny,W. Muenster,I. Timm

1964-05-15

Abstract:

What problem does this paper attempt to address?

Retrospective study of propionic acidemia using natural language processing in Mayo Clinic electronic health record data

Hannah Barman,Vanja Sikirica,Katherine Carlson,Eli Silvert,Katherine Brewer Carlson,Suzanne Boyer,Ruchira Glaser,Eva Morava,Tyler Wagner,Brendan Lanpher

DOI: https://doi.org/10.1016/j.ymgme.2023.107695

Abstract:Background: Propionic acidemia (PA) is a rare autosomal recessive organic acidemia that classically presents within the first days of life with a metabolic crisis or via newborn screening and is confirmed with laboratory tests. Limited data exist on the natural history of patients with PA describing presentation, treatments, and clinical outcomes. Objective: To retrospectively describe the natural history of patients with PA in a clinical setting from a real-world database using both structured and unstructured electronic health record (EHR) data using novel data extraction techniques in a unique care setting. Design/methods: This retrospective study used EHR data to identify patients with PA seen at the Mayo Clinic. Unstructured clinical text (medical notes, pathology reports) were analyzed using augmented curation natural language processing models to enhance analysis of data extracted by structured data fields (International Classification of Diseases 9th or 10th revision [ICD-9/-10] codes, Current Procedural Terminology [CPT] codes, and medication orders). De-identified health records were also manually reviewed by clinical scientists to ensure data accuracy and completeness. The index date was defined as the patient's date of PA diagnosis at the Mayo Clinic. Results were reported as aggregate descriptive statistics relative to patients' index dates. Complications, therapeutic interventions, laboratory tests, procedures, and hospitalization encounters related to PA were described at and within 6 months of the patient's index date, and from medical history available before the index date. Results: In total, 13 patients with PA were identified, with visits occurring from 1998 to 2022. Age at diagnosis ranged from birth to 3 years; age at initial evaluation at the Mayo Clinic ranged from 3 days to 28 years. The mean number of Mayo Clinic outpatient visits was 31 (median duration of care, 2 years). PA-related complications were documented in 85% of patients and included nutritional difficulties (46%), metabolic decompensation events (MDEs; 38%), neurologic abnormalities (38%), and cardiomyopathy (7%). One pair of affected siblings had mild symptoms and no complications or MDEs. All 5 patients with a history of MDEs presented with developmental delays. Among patients with MDEs, the mean frequency of outpatient clinical care visits was 10 per year, and 3 patients required inpatient hospitalization (mean duration, 16 days). The incidence of severe complications was higher among patients with MDEs than those without MDEs. Of the patients with MDEs, 2 experienced crises while receiving treatment at the Mayo Clinic, with 9 total MDEs occurring between the 2 patients. Symptoms at presentation included hyperammonemia (78%), fever and/or decreased nutritional intake (67%), hyperglycemia/hypoglycemia (56%), intercurrent upper respiratory infection and/or lethargy (44%), constipation (33%), altered mental status (33%), and cough (33%). Conclusions: This study highlights the range and frequency of clinical outcomes experienced by patients with PA and demonstrates the clinical burden of MDEs.
Intellectual disability and autism in propionic acidemia: a biomarker-behavioral investigation implicating dysregulated mitochondrial biology

Oleg A. Shchelochkov,Cristan A. Farmer,Colby Chlebowski,Dee Adedipe,Susan Ferry,Irini Manoli,Alexandra Pass,Samantha McCoy,Carol Van Ryzin,Jennifer Sloan,Audrey Thurm,Charles P. Venditti

DOI: https://doi.org/10.1038/s41380-023-02385-5

IF: 11

2024-01-12

Molecular Psychiatry

Abstract:Propionic acidemia (PA) is an autosomal recessive condition (OMIM #606054), wherein pathogenic variants in PCCA and PCCB impair the activity of propionyl-CoA carboxylase. PA is associated with neurodevelopmental disorders, including intellectual disability (ID) and autism spectrum disorder (ASD); however, the correlates and mechanisms of these outcomes remain unknown. Using data from a subset of participants with PA enrolled in a dedicated natural history study ( n = 33), we explored associations between neurodevelopmental phenotypes and laboratory parameters. Twenty (61%) participants received an ID diagnosis, and 12 of the 31 (39%) who were fully evaluated received the diagnosis of ASD. A diagnosis of ID, lower full-scale IQ (sample mean = 65 ± 26), and lower adaptive behavior composite scores (sample mean = 67 ± 23) were associated with several biomarkers. Higher concentrations of plasma propionylcarnitine, plasma total 2-methylcitrate, serum erythropoietin, and mitochondrial biomarkers plasma FGF21 and GDF15 were associated with a more severe ID profile. Reduced 1- 13 C-propionate oxidative capacity and decreased levels of plasma and urinary glutamine were also associated with a more severe ID profile. Only two parameters, increased serum erythropoietin and decreased plasma glutamine, were associated with ASD. Plasma glycine, one of the defining features of PA, was not meaningfully associated with either ID or ASD. Thus, while both ID and ASD were commonly observed in our PA cohort, only ID was robustly associated with metabolic parameters. Our results suggest that disease severity and associated mitochondrial dysfunction may play a role in CNS complications of PA and identify potential biomarkers and candidate surrogate endpoints.

biochemistry & molecular biology,neurosciences,psychiatry
Red Blood Cell Metabolism in Patients with Propionic Acidemia

Micaela Kalani Roy,Francesca Isabelle Cendali,Gabrielle Ooyama,Fabia Gamboni,Holmes Morton,Angelo D’Alessandro,Micaela Roy,Francesca Cendali

DOI: https://doi.org/10.3390/separations8090142

2021-09-03

Separations

Abstract:Propionic acidemia (PA) is a rare autosomal recessive disorder with an estimated incidence of 1:100,000 live births in the general population. Due in part to an insufficient understanding of the disease’s pathophysiology, PA is often associated with complications, and in severe cases can cause coma and death. Despite its association with hematologic disorders, PA’s effect on red blood cell metabolism has not been described. Mass spectrometry-based metabolomics analyses were performed on RBCs from healthy controls (n = 10) and PKD patients (n = 3). PA was associated with a significant decrease in the steady state level of glycolytic products and the apparent activation of the PPP. The PA samples showed decreases in succinate and increases in the downstream dicarboxylates of the TCA cycle. BCAAs were lowered in the PA samples and C3 carnitine, a direct metabolite of propionic acid, was increased. Trends in the markers of oxidative stress including hypoxanthine, allantoate and spermidine were the opposite of those associated with elevated ROS burden. The alteration of short chain fatty acids, the accumulation of some medium chain and long chain fatty acids, and decreased markers of lipid peroxidation in the PA samples contrasted with previous research. Despite limitations from a small cohort, this study provides the first investigation of RBC metabolism in PA, paving the way for targeted investigations of the critical pathways found to be dysregulated in the context of this disease.

chemistry, analytical
Systematic literature review and meta-analysis on the epidemiology of propionic acidemia

Tímea Almási,Lin T. Guey,Christine Lukacs,Kata Csetneki,Zoltán Vokó,Tamás Zelei

DOI: https://doi.org/10.1186/s13023-018-0987-z

2019-02-13

Orphanet Journal of Rare Diseases

Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Propionic acidemia (PA, OMIM #606054) is a serious, life-threatening, inherited, metabolic disorder caused by the deficiency of the mitochondrial enzyme propionyl-coenzyme A (CoA) carboxylase (EC 6.4.1.3). The primary objective of this study was to conduct a systematic literature review and meta-analysis on the epidemiology of PA. The literature search was performed covering Medline, Embase, Cochrane Database of Systematic Reviews, CRD Database, Academic Search Complete, CINAHL and PROSPERO databases. Websites of rare disease organizations were also searched for eligible studies. Of the 2338 identified records, 188 articles were assessed for eligibility in full text, 43 articles reported on disease epidemiology, and 31 studies were included into the quantitative synthesis. Due to the rarity of PA, broadly targeted population-based prevalence studies are not available. Nonetheless, implementation of newborn screening programs has allowed the estimation of the birth prevalence data of PA across multiple geographic regions. The pooled point estimates indicated detection rates of 0.29; 0.33; 0.33 and 4.24 in the Asia-Pacific, Europe, North America and the Middle East and North Africa (MENA) regions, respectively. Our systematic literature review and meta-analysis confirm that PA is an ultra-rare disorder, with similar detection rates across all regions with the exception of the MENA region where the disease, similar to other inherited metabolic disorders, is more frequent.</p>

genetics & heredity,medicine, research & experimental
Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital

Yi Liu,Zhehui Chen,Hui Dong,Yuan Ding,Ruxuan He,Lulu Kang,Dongxiao Li,Ming Shen,Ying Jin,Yao Zhang,Jinqing Song,Yaping Tian,Yongtong Cao,Desheng Liang,Yanling Yang

DOI: https://doi.org/10.1186/s13023-022-02271-3

2022-01-01

Orphanet Journal of Rare Diseases

Abstract:Background Propionic acidemia is a severe inherited metabolic disorder, caused by the deficiency of propionyl-CoA carboxylase which encoded by the PCCA and PCCB genes. The aim of the study was to investigate the clinical features and outcomes, molecular epidemiology and phenotype-genotype relationship in Chinese population. Methods We conducted a retrospective study of 60 Chinese patients diagnosed at Peking University First Hospital from 2007 to 2020. Their clinical and laboratory data were reviewed. The next-generation sequencing was conducted on blood samples from 58 patients. Results Only 5 (8.3%) patients were identified by newborn screening. In the rest 55 patients, 25 had early-onset (≤ 3 months) disease and 30 had late-onset (> 3 months) disease. Neurological abnormalities were the most frequent complications. Five cases detected by newborn screening had basically normal development. Nine (15%) cases died in our cohort. 24 patients (41.4%) harbored PCCA variants, and 34 (58.6%) harbored PCCB variants. 30 (11 reported and 19 novel) variants in PCCA and 28 (18 reported and 10 novel) variants in PCCB mere identified. c.2002G>A and c.937C>T in PCCA , and c.838dupC in PCCB were the most common variants in this cohort, with the frequency of 13.9% (6/44 alleles), 13.9% (6/44 alleles) and 12.5% (8/64 alleles), respectively. There was no difference in clinical features and outcomes between patients with PCCA and PCCB variants. Certain variants with high frequencies and homozygotes may be associated with early-onset or late-onset propionic acidemia. Conclusions Although the genotype–phenotype correlation is still unclear, certain variants seemed to be related to early-onset or late-onset propionic acidemia. Our study further delineated the complex clinical manifestations of propionic acidemia and expanded the spectrum of gene variants associated with propionic acidemia.
[Screening for Newborn Organic Aciduria in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Fang Hong,Xinwen Huang,Yu Zhang,Jianbin Yang,Fan Tong,Huaqing Mao,Xiaolei Huang,Xuelian Zhou,Rulai Yang,Zhengyan Zhao

DOI: https://doi.org/10.3785/j.issn.1008-9292.2017.06.03

2017-01-01

Abstract:OBJECTIVE To analyze the results and follow up data of screening for newborn organic aciduria in Zhejiang province. METHODS The results and follow-up data of 1 861 262 newborns from Zhejiang province undergoing screening for organic aciduria during January 2009 and December 2016 were retrospectively analyzed. The acylcarnitine spectrum in urine samples was detected by tandem mass spectrum (MS/MS) and the positive patients were confirmed by urine gas chromatography mass spectrometry and/or gene analysis. RESULTS Ninety two cases of organic aciduria were confirmed with a prevalence of 1:20 200. Among 40 cases of methylmalonic academia (MMA), 13 (32.5%) were of MMA simple type and 27 (67.5%) were combined type. Genetic analysis showed 6 cases of MUT type and 1 case of CblB type out of 7 patients with MMA simple type, 10 cases of CblC and 1 case of CblF out of 11 patients with combined type, respectively. Six patients had propionic academia with a prevalence of 1:310 200, 7 had isovaleric academia (1:265 900), 6 had glutaric academia type 1 (1:310 200), 27 had 3-methylcrotonyl-CoA carboxylase deficiency (MCC, 1:68 900), 1 had 3-hydroxy-3-methylglutaric aciduria (1:1 861 300), 2 had β-ketothiolase deficiency (1:960 600), and 3 had biotinidase deficiency/holocarboxylase synthetase deficiency (1:620 400). Thirty-one patients had a disease onset at neonatal period, and 15 at post-neonatal period. Thirty-three patients had brain involvements or cranial imaging disorders. Three patients with MMA had kidney diseases or heomlytic uremic syndrome, and 3 had myocardial impairments. Twenty patients died during the follow-up. CONCLUSIONS MMA is the most common newborn organic aciduria in Zhejiang province. Except MCC, most organic aciduria may lead to metabolism decompensation, complications or even death.
Severe anemia in patients with Propionic acidemia is associated with branched-chain amino acid imbalance

Sinziana Stanescu,Amaya Belanger-Quintana,Borja Manuel Fernandez-Felix,Francisco Arrieta,Victor Quintero,Maria Soledad Maldonado,Patricia Alcaide,Mercedes Martínez-Pardo

DOI: https://doi.org/10.1186/s13023-021-01865-7

2021-05-18

Orphanet Journal of Rare Diseases

Abstract:Abstract Background Propionic acidemia (PA), an inborn error of metabolism, is caused by a deficiency in propionyl-CoA carboxylase. Patients have to follow a diet restricted in the propiogenic amino acids isoleucine (Ile), valine (Val), methionine (Met) and threonine (Thr); proper adherence can prevent and treat acute decompensation and increase life expectancy. However, chronic complications occur in several organs even though metabolic control may be largely maintained. Bone marrow aplasia and anemia are among the more common. Materials and methods In this retrospective study, data for patients with PA being monitored at the Hospital Ramón y Cajal (Madrid, Spain) (n = 10) in the past 10 years were examined to statistically detect relationships between persistent severe anemia outside of metabolic decompensation episodes and dietary practices such as natural protein intake and medical food consumption (special mixture of precursor-free amino acids) along with plasma levels of branched-chain amino acids (BCAA). High ferritin levels were deemed to indicate that a patient had received repeated transfusions for persistent anemia since data on hemoglobin levels at the moment of transfusion were not always passed on by the attending centers. Results Three patients had severe, persistent anemia that required repeated blood transfusions. Higher medical food consumption and plasma Leu levels were associated with iron overload. Notably, natural protein intake and plasma Val were negatively correlated with ferritin levels. We also observed an inverse relationship between plasma Val/Leu and Ile/Leu ratios and ferritin. Conclusion The present results suggest that severe anemia in patients with PA might be associated with low natural protein intake and BCAA imbalance.

genetics & heredity,medicine, research & experimental
Long-term Follow-Up of Children with Carbamoyl Phosphate Synthase 1 Deficiency Detected in Newborn Screening.

Zhanming Zhang,Fan Tong,Chi Chen,Ting Zhang,Guling Qian,Xin Yang,Xinwen Huang,Rulai Yang,Zhengyan Zhao

DOI: https://doi.org/10.3724/zdxbyxb-2023-0359

2023-01-01

Abstract:OBJECTIVES:To investigate genotype-phenotype characteristics and long-term prognosis of neonatal carbamoyl phosphate synthetase 1 (CPS1) deficiency among children through newborn screening in Zhejiang province.METHODS:The clinical and follow-up data of children with CPS1 deficiency detected through neonatal screening and confirmed by tandem mass spectrometry and genetic testing in Zhejiang Province Newborn Disease Screening Center from September 2013 to August 2023 were retrospectively analyzed.RESULTS:A total of 4 056 755 newborns were screened and 6 cases of CPS1 deficiency were diagnosed through phenotypic and genetic testing. Ten different variations of CPS1 genewere identified in genetic testing, including 2 known pathogenic variations (c.2359C>T and c.1549+1G>T) and 8 unreported variations (c.3405-1G>T, c.2372C>T, c.1436C>T, c.2228T>C, c.2441G>A, c.3031G>A, c.3075T>C and c.390-403del). All patients had decreased citrulline levels (2.72-6.21 μmol/L), and varying degrees of elevated blood ammonia. The patients received restricted natural protein intake (special formula), arginine and supportive therapy after diagnosis, and were followed-up for a period ranging from 9 months to 10 years. Three patients experienced hyperammonemia, and one patient each had attention deficit hyperactivity disorder, transient facial twitching and increased muscle tone. One patient died, while the other five surviving patients had normal scores of the Ages & Stages Questionnaires (ASQ) and Griffiths Development Scales up to the present time; 4 cases had combined height or weight lag and one case was normal in height and weight.CONCLUSIONS:Low citrulline levels and hyperammonemia are common in CPS1 deficiency patients in Zhejiang. Most gene variants identified were specific to individual families, and no hotspot mutations were found. Early diagnosis through newborn screening and following standardized treatment can significantly improve the prognosis of the patients.
Gene mutation analysis in patients with propionic acidemia]

Yu-hui Hu,Lian-shu Han,Jun Ye,Wen-juan Qiu,Ya-fen Zhang,Yan-ling Yang,Li Liu,Hong-wei Ma,Xiao-lan Gao,Xue-fan Gu

2008-01-01

Abstract:Propionic acidemia is a common organic acidemia, caused by deficiency of propionyl-CoA carboxylase (PCC), which catalyzes the carboxylation of propionyl-CoA to D-methylmalonyl-CoA. PCC is a dodecameric enzyme of alpha-PCC and beta-PCC subunits, nuclearly encoded by genes PCCA and PCCB, respectively. Mutation in either gene cause propionic acidemia, the PCCA gene is located on chromosome 13q32 with 24 exons and the PCCB gene is located on chromosome 3q13.2-q22 with 15 exons. In this study, we analyzed gene mutations of 11 PCCA and PCCB deficient patients from China and to explore the possible mutation spectrum.All 39 exons of PCCA and PCCB genes in 11 unrelated Chinese PA patients were analyzed by polymerase chain reaction (PCR) and direct sequencing. Genomic DNA was extracted using phenol-chloroform method from the peripheral blood leukocytes of each patient. PCR amplification products were checked by 1.8% agarose gel electrophoresis and were subsequently sequenced with ABI 3700 Automated DNA Sequencer.The authors identified 13 PA mutations, 8 affecting the PCCA gene, 5 affecting the PCCB gene, including 10 novel mutations and 3 previously reported mutations. Three missense mutations (1079T > G, 1102G > C and 1850T > C), one splicing mutation (716-2A > G) and one short deletion (1863delA) were found in alpha-PCC subunit while three missense mutations (484G > A, 601G > A and 1253C > T) and two short insertion-deletions (167-179del13ins1, 560-561delCCinsT) were found in beta-PCC subunit. The 167-179del13ins1 change was identified in two homozygous PA patients, with allelic frequency of 40% in beta-PCC subunit deficiencies.Thirteen mutations were found in 11 Chinese PA patients including ten novel mutations. No mutation is predominant in Chinese PCCA and PCCB deficient patients.
Gene mutation analysis in pafients with propionic acidemia

Yu-hui HU,Lian-shu HAN,Jun YE,Wen-juan QIU,Ya-fen ZHANG,Yan-ling YANG,Li LIU,Hong-wei MA,Xiao-lan GAO,Xue-fan GU

DOI: https://doi.org/10.3321/j.issn:0578-1310.2008.06.005

2008-01-01

Abstract:Objective Propionic acidemia is a common organic acidemia,caused by deficiency of propionyl-CoA carboxylase(PCC),which catalyzes the carboxylation of propionyl-CoA to D-methylmalonyl-CoA.PCC is a dodecameric enzyme of t-PCC and β-PCC subunits.nuclearly encoded by genes PCCA and PCCB,respectively.Mutation in either gene cause propionic acidemia.the PCCA gene is located on chmmosome 13q32 with 24 exons and the PCCB gene is located on chromosome 3q13.2-q22 with 15 exons. In this study.we analyzed gene mutations of 11 PCCA and PCCB deficient patients from China and to explore the possible mutation spectrum.Methods All 39 exons of PCCA and PCCB genes in 11 unrelated Chinese PA patients were analyzed by polymerase chain reaction(PCR)and direct sequencing.Genomic DNA was extracted using phenol-chloroform method from the peripheral blood leukocytes of each patient.PCR amplification products were checked by 1.8%agarose gel electrophoresis and were subsequently sequenced with ABI 3700 Automated DNA Sequencer.Results The authors identified 13 PA mutations.8 affecting the PCCA gene,5 affecting the PCCB gene,including 10 novel mutations and 3 previously reported mutations.Three missense mutations(1079T>G,1102G>C and 1850T>C).one splicing mutation(716- 2A>G)and one short deletion(1863delA)were found in α-PCC subunit while three missense mutations (484G>A,601G>A and 1253C>T)and two short insertion-deletions(167-179dell3insl.560- 561delCCinsT)were found in β-PCC subunit.The 167-179del13insl change was identified in two homozygous PA patients,with allelic frequency of 40%in B-PCC subunit deficiencies.Conclusion Thirteen mutations were found in 11 Chinese PA patients including ten novel mutations.No mutation is predominant in Chinese PCCA and PCCB deficient patients.
Propionic acidemia in mice: Liver acyl-CoA levels and clinical course

Chen Zhao,Youlin Wang,Hao Yang,Shupei Wang,Marie-Christine Tang,Denis Cyr,Fabienne Parente,Pierre Allard,Paula Waters,Alexandra Furtos,Gongshe Yang,Grant A Mitchell,Grant A. Mitchell

DOI: https://doi.org/10.1016/j.ymgme.2021.11.011

IF: 4.204

2022-01-01

Molecular Genetics and Metabolism

Abstract:Propionic acidemia (PA) is a severe autosomal recessive metabolic disease caused by deficiency of propionyl-CoA carboxylase (PCC). We studied PA transgenic (Pat) mice that lack endogenous PCC but express a hypoactive human PCCA cDNA, permitting their survival. Pat cohorts followed from 3 to 20 weeks of age showed growth failure and lethal crises of lethargy and hyperammonemia, commoner in males (27/50, 54%) than in females (11/52, 21%) and occurring mainly in Pat mice with the most severe growth deficiency. Groups of Pat mice were studied under basal conditions (P-Ba mice) and during acute crises (P-Ac). Plasma acylcarnitines in P-Ba mice, compared to controls, showed markedly elevated C3- and low C2-carnitine, with a further decrease in C2-carnitine in P-Ac mice. These clinical and biochemical findings resemble those of human PA patients. Liver acyl-CoA measurements showed that propionyl-CoA was a minor species in controls (propionyl-CoA/acetyl-CoA ratio, 0.09). In contrast, in P-Ba liver the ratio was 1.4 and in P-Ac liver, 13, with concurrent reductions of the levels of acetyl-CoA and other acyl-CoAs. Plasma ammonia levels in control, P-Ba and P-Ac mice were 109 ± 10, 311 ± 48 and 551 ± 61 μmol/L respectively. Four-week administration to Pat mice, of carglumate (N-carbamyl-L-glutamic acid), an analogue of N-carbamylglutamate, the product of the only acyl-CoA-requiring reaction directly related to the urea cycle, was associated with increased food consumption, improved growth and absence of fatal crises. Pat mice showed many similarities to human PA patients and provide a useful model for studying tissue pathophysiology and treatment outcomes.

genetics & heredity,endocrinology & metabolism,medicine, research & experimental
[Screening for Fatty Acid Oxidation Disorders of Newborns in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Xinwen Huang,Yu Zhang,Fang Hong,Jing Zheng,Jianbin Yang,Fan Tong,Huaqing Mao,Xiaolei Huang,Xuelian Zhou,Rulai Yang,Zhengyan Zhao

DOI: https://doi.org/10.3785/j.issn.1008-9292.2017.06.04

2017-01-01

Abstract:OBJECTIVE:To analyze the result and follow-up data of screening for newborn amino acid metabolic disorders in Zhejiang province.METHODS:A total of 1 861 262 newborns were screened for amino acid metabolic disorders during January 2009 and December 2016 in Zhejiang province. The screening results and the follow-up data were analyzed retrospectively.RESULTS:One hundred and sixty four cases were diagnosed as amino acid metabolic disorders with a prevalence of 1:11 349, including 83 with hyperphenylalaninaemia (1:22 400), 29 with neonatal intrahepatic cholestasis caused by citrin deficiency (1:64 138), 16 with methionine S-adenosyltransferase deficiency (1:116 250), 9 with maple syrup urine disease (1:206 667), 8 with argininemia (1:232 500), 7 with citrullinemia type Ⅰ (1:265 700), 6 with hyperprolinemia type Ⅰ (1:310 000), and 2 with carbamylphosphate synthetase Ⅰ deficiency(1:930 000). In addition, ornithine transcarbamylase deficiency, cystathionine β-synthase deficiency, argininosucoinate aciduria and tyrosinemia type Ⅰ were detected in one patient for each, respectively. Two patients had developmental delay, 7 patients were dead, and 2 cases of maple syrup urine disease were lost to follow-up.CONCLUSIONS:Hyperphenylalaninaemia is the most common amino acid metabolic disease in newborns in Zhejiang province. Patients with amino acid metabolic disorders identified in newborn screening program can have chance for normal growth development by intervention.
Development of ELISA and immunochromatographic assay for the detection of neomycin.

Yong Jin,Jin-wook Jang,Mun-Han Lee,Chang-Hoon Han

DOI: https://doi.org/10.1016/J.CCA.2005.07.024

2006-02-01

Abstract:
Relief of CoA sequestration and restoration of mitochondrial function in a mouse model of propionic acidemia

Chitra Subramanian,Matthew W. Frank,Rajendra Tangallapally,Mi‐Kyung Yun,Stephen W. White,Richard E. Lee,Charles O. Rock,Suzanne Jackowski

DOI: https://doi.org/10.1002/jimd.12570

IF: 4.7501

2022-10-19

Journal of Inherited Metabolic Disease

Abstract:Propionic acidemia (PA, OMIM 606054) is a devastating inborn error of metabolism arising from mutations that reduce the activity of the mitochondrial enzyme propionyl‐CoA carboxylase (PCC). The defects in PCC reduce the concentrations of nonesterified coenzyme A (CoASH), thus compromising mitochondrial function and disrupting intermediary metabolism. Here, we use a hypomorphic PA mouse model to test the effectiveness of BBP‐671 in correcting the metabolic imbalances in PA. BBP‐671 is a high‐affinity allosteric pantothenate kinase activator that counteracts feedback inhibition of the enzyme to increase the intracellular concentration of CoA. Liver CoASH and acetyl‐CoA are depressed in PA mice and BBP‐671 treatment normalizes the cellular concentrations of these two key cofactors. Hepatic propionyl‐CoA is also reduced by BBP‐671 leading to an improved intracellular C3:C2‐CoA ratio. Elevated plasma C3:C2‐carnitine ratio and methylcitrate, hallmark biomarkers of PA, are significantly reduced by BBP‐671. The large elevations of malate and α‐ketoglutarate in the urine of PA mice are biomarkers for compromised tricarboxylic acid cycle activity and BBP‐671 therapy reduces the amounts of both metabolites. Furthermore, the low survival of PA mice is restored to normal by BBP‐671. These data show that BBP‐671 relieves CoA sequestration, improves mitochondrial function, reduces plasma PA biomarkers and extends the lifespan of PA mice, providing the preclinical foundation for the therapeutic potential of BBP‐671. This article is protected by copyright. All rights reserved.

genetics & heredity,endocrinology & metabolism,medicine, research & experimental
Combinations of exonic deletions and rare mutations lead to misdiagnosis of propionic acidemia

Handuo Wang,Lanlan Meng,Wen Li,Juan Du,Yueqiu Tan,Fei Gong,Guangxiu Lu,Ge Lin,Qianjun Zhang

DOI: https://doi.org/10.1016/j.cca.2019.12.021

Abstract:Propionic acidemia (PA) is an inborn metabolic error characterized by the accumulation of propionic acid due to deficiency of propionyl-CoA carboxylase (PCC). In this study, we present an intractable case with PCC activity defects. Although next-generation sequencing was applied twice to test genetic defects of the patients, no pathogenic mutations of a metabolic disease gene were identified. Mutations related to the disease were screened in prenatal diagnosis, but the mother still gave birth to an unhealthy neonate. We analyzed the second sequencing data and found that a novel synonymous PCCA mutation c.1746 G>C (p.S582S), which leads to an exon 19 skip, was screened out. Furthermore, a deletion mutation covering exon 3 and exon 4 of the PCCA gene was identified using q-PCR and DNA breakpoint test. Both of these can result in the loss of PCCA protein function. The finding expands the mutation spectrum of the PCCA gene and indicates that another technology such as cDNA analysis, multiplex ligation-dependent probe amplification (MLPA), or long-read whole-genome sequencing should be considered to improve the detection rates of special cases.
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci

J. Tapsall

DOI: https://doi.org/10.1136/sti.2008.035337

2009-03-03

Sexually Transmitted Infections

Abstract:To ascertain recommendations for the treatment of gonorrhoea in the WHO Western Pacific Region (WPR) following the emergence of “cephalosporin-resistant” Neisseria gonorrhoeae and to relate these to clinical and laboratory measures directed towards disease and antibiotic resistance control. WHO WPR Gonococcal Antimicrobial Resistance Programme members provided data on the type, dose and source of third-generation cephalosporins recommended for the treatment of gonorrhoea. Ceftriaxone was recommended more widely (11/15 respondents) than cefixime (five centres). No cephalosporins were recommended in three jurisdictions. One other oral (ceftibuten) and injectable (cefodizime) agent was recommended. Uniform (400 mg) doses of cefixime were recommended but ceftriaxone regimens ranged between 125 mg and 1 g, with nine of 11 respondents using a 250 mg dose. Both generic and proprietary preparations were widely used. Third-generation cephalosporins are widely recommended for the treatment of gonorrhoea in the WPR, with injectable ceftriaxone more extensively so than oral cefixime and in an expanded dose range. Few other cephalosporins were recommended. Current knowledge suggests that the trend towards ceftriaxone treatment in higher doses may decrease the impact of the circulation of “cephalosporin-resistant” gonococci in the WPR. These recommendations represent public sector practice only and of themselves are unlikely to contain the further spread of “cephalosporin-resistant” gonococci because of the general clinical use of cephalosporins. Optimisation of strategies for laboratory detection of third-generation cephalosporin resistance can be simplified in the WPR because of the restricted spectrum of cephalosporins recommended. Additional efforts are urgently required for both disease and antibiotic resistance control in gonorrhoea.
Metabolic and Proteomic Profiles Reveal the Response of the ASD-Associated Resistant Strain 6-1 of Lactobacillus Plantarum to Propionic Acid

Rongrong Yu,Muchen Zhang,Temoor Ahmed,Zhifeng Wu,Luqiong Lv,Guoling Zhou,Bin Li

DOI: https://doi.org/10.3390/ijerph192417020

IF: 4.614

2022-01-01

International Journal of Environmental Research and Public Health

Abstract:Autism spectrum disorder (ASD) seriously affects children’s health. In our previous study, we isolated and identified a bacterium (Lactobacillus plantarum strain 6-1) that is resistant to propionic acid (PA), which has been reported to play a significant role in the formation of ASD. In order to elucidate the mechanism of the resistance to PA, this study investigated the change in the metabolic and proteomic profile of L. plantarum strain 6-1 in the presence and absence of PA. The results show that 967 and 1078 proteins were specifically identified in the absence and the presence of PA, respectively, while 616 proteins were found under both conditions. Gene ontology enrichment analysis of 130 differentially expressed proteins accumulated in the presence and absence of PA indicated that most of the proteins belong to biological processes, cellular components, and molecular functions. Pathway enrichment analysis showed a great reduction in the metabolic pathway-related proteins when this resistant bacterium was exposed to PA compared to the control. Furthermore, there was an obvious difference in protein–protein interaction networks in the presence and the absence of propionic acid. In addition, there was a change in the metabolic profile of L. plantarum strain 6-1 when this bacterium was exposed to PA compared to the control, while six peaks at 696.46, 1543.022, 1905.241, 2004.277, 2037.374, and 2069.348 m/z disappeared. Overall, the results could help us to understand the mechanism of the resistance of gut bacteria to PA, which will provide a new insight for us to use PA-resistant bacteria to prevent the development of ASD in children.
Identification and characterization of the largest deletion in the PCCA gene causing severe acute early-onset form of propionic acidemia

Fereshteh Maryami,Elham Davoudi-Dehaghani,Nasrin Khalesi,Elham Rismani,Hamzeh Rahimi,Saeed Talebi,Sirous Zeinali

DOI: https://doi.org/10.1007/s00438-023-02023-3

IF: 2.98

2023-05-04

Molecular Genetics and Genomics

Abstract:Whole-exome sequencing (WES) is an excellent method for the diagnosis of diseases of uncertain or heterogeneous genetic origin. However, it has limitations for detecting structural variations such as InDels, which the bioinformatics analyzers must be aware of. This study aimed at using WES to evaluate the genetic cause of the metabolic crisis in a 3-day-old neonate admitted to the neonatal intensive care unit (NICU) and deceased after a few days. Tandem mass spectrometry (MS/MS) showed a significant increase in propionyl carnitine (C3), proposing methylmalonic acidemia (MMA) or propionic acidemia (PA). WES demonstrated a homozygous missense variant in exon 4 of the BTD gene (NM_000060.4( BTD ):c.1330G > C), responsible for partial biotinidase deficiency. Segregation analysis of the BTD variant revealed the homozygous status of the asymptomatic mother. Furthermore, observation of the bam file, around genes responsible for PA or MMA, by Integrative Genomics Viewer (IGV) software displayed a homozygous large deletion in the PCCA gene. Comprehensive confirmatory studies identified and segregated a novel outframe deletion of 217,877 bp length, "NG_008768.1:g.185211_403087delinsTA", extended from intron 11 to 21 of the PCCA , inducing a premature termination codon and activation of nonsense-mediated mRNA decay (NMD). Homology modeling of the mutant PCCA demonstrated eliminating the protein's active site and critical functional domains. Thereupon, this novel variant is suggested as the largest deletion in the PCCA gene, causing an acute early-onset PA. These results could expand the PCCA variants spectrum, and improve the existing knowledge on the molecular basis of PA, as well as provide new evidence of pathogenicity of the variant (NM_000060.4( BTD ):c.1330G > C.

genetics & heredity,biochemistry & molecular biology
Isolation, Identification and Characterization of Propionic Acid Bacteria Associated with Autistic Spectrum Disorder.

Rongrong Yu,Zhifeng Wu,Shuhui Wang,Muchen Zhang,Guoling Zhou,Bin Li

DOI: https://doi.org/10.1016/j.micpath.2020.104371

IF: 3.848

2020-01-01

Microbial Pathogenesis

Abstract:Autism spectrum disorder (ASD) seriously affects children's health. Recently, propionic acid (PA) has been reported to play a significant role in the formation of ASD. In this study, we investigated the community structure of PA-related bacteria in healthy and ASD children by isolation and culture, while a group of representative PA-related bacteria were identified and characterized based on colony morphological observation, physiological and biochemical tests, as well as living/dead cells staining analysis and 16S rRNA gene sequencing. The results showed that the number of PA-related bacteria in healthy children was >100-fold higher than that in ASD children, while compared to healthy children, greater diversity was found in PA-associated bacteria from ASD children. The sensitivity of the representative strains to PA was affected by bacterial species, PA concentration and incubation time. The decrease of pH value was found in PA-resistant Lactobacillus plantarum strain 6-1 but not in PA-sensitive Enterococcus lactis strain 4-1, while biofilm formation of both strains were unaffected by PA. Furthermore, PA inhibited the propagation of the two selected bacteria rather than killed them, while the greater inhibitory effect was observed on strain 4-1. Overall, the result is of great significance for revealing the role of PA-related bacteria in development of ASD.
Clinical Onset and Prognosis of Asian Children with Organic Acidemias, As Detected by Analysis of Urinary Organic Acids Using GC/MS, Instead of Mass Screening

Daisuke Hori,Yuki Hasegawa,Masahiko Kimura,Yanling Yang,Iswar C. Verma,Seiji Yamaguchi

DOI: https://doi.org/10.1016/j.braindev.2004.04.004

IF: 2.272

2005-01-01

Brain and Development

Abstract:Organic acidemias (OAs) have been detected worldwide in symptomatic patients using gas chromatography mass spectrometry. We diagnosed 188 Asian cases of OAs by analysis of urinary organic acids and investigated their clinical onset and outcome. Methylmalonic acidemia (MMA) was most common (74 cases), followed by propionic acidemia (23 cases), ornitine transcarbamylase deficiency (22 cases), and multiple carboxylase deficiency (15 cases). For these 188 patients, onset was most frequent in the neonatal period or early infancy. Approximately 30% of the patients had a family history of similar symptoms or diseases. Although the outcome of OA patients varied, patients with early onset generally had poor outcomes despite early detection. Of the 45 MMA patients whose clinical data were available, 25 were clinically vitamin B12-responsive, while the remaining 20 were non-responsive. A favorable outcome was obtained in 7 of the 25 B12-responsive patients, and in only 3 of the 20 B12-nonresponsive patients. It was suggested that even in B12-responsive MMA cases, earlier detection and B12 therapy were needed to improve the prognosis. We concluded that detection of such patients at the presymptomatic stages using newborn mass screening is essential for prognosis improvement with OAs.

[ROENTGEN DIAGNOSIS OF RENAL HYPERTENSION CAUSED BY OBSTRUCTION. (NEW METHODS AND RESULTS)].

Retrospective study of propionic acidemia using natural language processing in Mayo Clinic electronic health record data

Intellectual disability and autism in propionic acidemia: a biomarker-behavioral investigation implicating dysregulated mitochondrial biology

Red Blood Cell Metabolism in Patients with Propionic Acidemia

Systematic literature review and meta-analysis on the epidemiology of propionic acidemia

Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital

[Screening for Newborn Organic Aciduria in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Severe anemia in patients with Propionic acidemia is associated with branched-chain amino acid imbalance

Long-term Follow-Up of Children with Carbamoyl Phosphate Synthase 1 Deficiency Detected in Newborn Screening.

Gene mutation analysis in patients with propionic acidemia]

Gene mutation analysis in pafients with propionic acidemia

Propionic acidemia in mice: Liver acyl-CoA levels and clinical course

[Screening for Fatty Acid Oxidation Disorders of Newborns in Zhejiang Province:Prevalence, Outcome and Follow-Up].

Development of ELISA and immunochromatographic assay for the detection of neomycin.

Relief of CoA sequestration and restoration of mitochondrial function in a mouse model of propionic acidemia

Combinations of exonic deletions and rare mutations lead to misdiagnosis of propionic acidemia

Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci

Metabolic and Proteomic Profiles Reveal the Response of the ASD-Associated Resistant Strain 6-1 of Lactobacillus Plantarum to Propionic Acid

Identification and characterization of the largest deletion in the PCCA gene causing severe acute early-onset form of propionic acidemia

Isolation, Identification and Characterization of Propionic Acid Bacteria Associated with Autistic Spectrum Disorder.

Clinical Onset and Prognosis of Asian Children with Organic Acidemias, As Detected by Analysis of Urinary Organic Acids Using GC/MS, Instead of Mass Screening